AAD and CDC Urge Patients to Follow Guidance to Avoid Counterfeit Botox Injectables
MDSpire News
April 30, 2024
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

The AAD warns patients about counterfeit botulinum toxin injectables that may cause severe complications.
The CDC is investigating adverse reactions linked to counterfeit Botox products with the FDA and health departments.
Reports from nine states indicate severe complications from counterfeit Botox, including visual impairment and strokes.
55% of patients experiencing reactions to counterfeit injectables required hospitalization.
Patients are advised to ensure Botox is administered by licensed professionals in medical settings.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: